HICON Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Hicon, and what generic alternatives are available?
Hicon is a drug marketed by Jubilant and is included in one NDA.
The generic ingredient in HICON is sodium iodide i-131. There are one thousand four hundred and seventy-two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the sodium iodide i-131 profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HICON?
- What are the global sales for HICON?
- What is Average Wholesale Price for HICON?
Summary for HICON
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 8 |
Patent Applications: | 39 |
What excipients (inactive ingredients) are in HICON? | HICON excipients list |
DailyMed Link: | HICON at DailyMed |
Pharmacology for HICON
Drug Class | Radioactive Therapeutic Agent |
Mechanism of Action | Radiopharmaceutical Activity |
US Patents and Regulatory Information for HICON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jubilant | HICON | sodium iodide i-131 | SOLUTION;ORAL | 021305-002 | Jan 24, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Jubilant | HICON | sodium iodide i-131 | SOLUTION;ORAL | 021305-007 | Dec 5, 2011 | AA | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Jubilant | HICON | sodium iodide i-131 | SOLUTION;ORAL | 021305-003 | Jan 24, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Jubilant | HICON | sodium iodide i-131 | SOLUTION;ORAL | 021305-005 | Apr 4, 2006 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |